首页/数据集/Changes in immunological profile after therapy switch to rituximab.

Changes in immunological profile after therapy switch to rituximab.

Figshare2018-02-09 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Changes_in_immunological_profile_after_therapy_switch_to_rituximab_/5871414 数据链接链接失效反馈

官方服务：

资源简介：

Changes in immunological profile after therapy switch to rituximab.

应用场景：

创建时间：

2018-02-09

自身免疫性大疱性皮肤病

利妥昔单抗疗效评估

Background: Although rituximab is known to be effective in the treatment of pemphigus, its role in subepidermal autoimmune blistering diseases is unclear and currently limited to off-label use. Summar

Figshare2022-10-27 更新60

Supplementary data for rituximab treatment of pemphigus in a Chinese population

天疱疮治疗

利妥昔单抗疗效评估

Pemphigus is a life-threatening autoimmune dermatosis due to both extensive skin damage and the side effects of conventional high-dose corticosteroid treatment. Rituximab has been reported to be effec

NIAID Data Ecosystem30

The association between response rate, progression-free survival, and overall survival in relapsed/refractory chronic lymphocytic leukemia and mantle cell leukemia since the introduction/adoption of rituximab

用药研究

利妥昔单抗疗效评估

Systematic review protocol registration

DataCite Commons2020-08-03 更新10

Supplementary Material for: Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience

天疱疮临床治疗

利妥昔单抗疗效评估

Introduction: In a randomized prospective trial, adjuvant rituximab was more efficacious than corticosteroids alone in the treatment of pemphigus; however, real-life data are limited. Rituximab treatm

NIAID Data Ecosystem30

Monocytes in peripheral blood. Data is displayed as mean ± standard deviation.

外周血单个核细胞（PBMC）

免疫学监测

Monocytes in peripheral blood. Data is displayed as mean ± standard deviation.

Figshare2015-12-02 更新20